BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 6944532)

  • 1. Elevated urine estrogen and pregnanediol levels in daughters of breast cancer patients.
    Trichopoulos D; Brown JB; Garas J; Papaioannou A; MacMahon B
    J Natl Cancer Inst; 1981 Sep; 67(3):603-6. PubMed ID: 6944532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic status, urine estrogens, and breast cancer risk.
    Trichopoulos D; MacMahon B; Brown J
    J Natl Cancer Inst; 1980 Apr; 64(4):753-5. PubMed ID: 6928988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen profiles of primiparous and nulliparous women in Athens, Greece.
    Trichopoulos D; Cole P; Brown JB; Goldman MB; MacMahon B
    J Natl Cancer Inst; 1980 Jul; 65(1):43-6. PubMed ID: 6930516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen profiles of premenopausal women with breast cancer.
    Cole P; Cramer D; Yen S; Paffenbarger R; MacMahon B; Brown J
    Cancer Res; 1978 Mar; 38(3):745-8. PubMed ID: 626978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine estrogens, frequency of ovulation, and breast cancer risk: case-control study in premenopausal women.
    MacMahon B; Cole P; Brown JB; Paffenbarger R; Trichopoulos D; Yen S
    J Natl Cancer Inst; 1983 Feb; 70(2):247-50. PubMed ID: 6571932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and measurement of urinary estrone, estradiol-17 beta, estriol, pregnanediol and androsterone during the menstrual cycle of the orangutan.
    Collins DC; Graham CE; Preedy JR
    Endocrinology; 1975 Jan; 96(1):93-101. PubMed ID: 162882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estrogen excretion and sex chromatin content in the tumor cells of breast cancer patients].
    Tsygan VM; Russu ID; Skul'skaia SF
    Vopr Onkol; 1975; 21(11):26-9. PubMed ID: 1210115
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between urine and plasma estrogen ratios.
    Longcope C; Pratt JH
    Cancer Res; 1978 Nov; 38(11 Pt 2):4025-8. PubMed ID: 698950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary oestrogens and pregnandiol in breast cancer patients.
    Zaki K; El-Kharadly M; El-Faras A; Nour H; Kamel NI
    Endokrinologie; 1982 Feb; 79(1):49-56. PubMed ID: 7084131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen profiles in young women: effect of maternal history of breast cancer.
    Morgan RW; Vakil DV; Brown JB; Elinson L
    J Natl Cancer Inst; 1978 May; 60(5):965-7. PubMed ID: 642038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer.
    Morreal CE; Dao TL; Nemoto T; Lonergan PA
    J Natl Cancer Inst; 1979 Nov; 63(5):1171-4. PubMed ID: 291747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of the luteotropic hormone activity of blood and urinary steroid excretion in diseases of the breast].
    Márton Z; Gáti I; Doszpod J; Preisz J; Kecskés L
    Arch Geschwulstforsch; 1969; 34(2):179-87. PubMed ID: 5407886
    [No Abstract]   [Full Text] [Related]  

  • 14. Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women.
    Falk RT; Gail MH; Fears TR; Rossi SC; Stanczyk F; Adlercreutz H; Kiura P; Wahala K; Donaldson JL; Vaught JB; Fillmore CM; Hoover RN; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):567-77. PubMed ID: 10385149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the secretory activity of the adrenal cortex and gonads in women with epilepsy. II. Urinary excretion of estrogen fractions and alpha and beta pregnanediol during the 2 days preceding menstrual bleeding].
    Buntner B; Rościszewska D
    Neurol Neurochir Pol; 1985; 19(6):480-5. PubMed ID: 3835487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The urinary excretion of estrogens in patients with far advanced breast cancer during treatment with prednisolone].
    Konoplia EF
    Vopr Onkol; 1968; 14(12):12-8. PubMed ID: 5714178
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal estrogen conjugation in women at risk for familial breast cancer at the periovulatory stage of the menstrual cycle.
    Fishman J; Bradlow HL; Fukushima DK; O'Connor J; Rosenfeld RS; Graepel GJ; Elston R; Lynch H
    Cancer Res; 1983 Apr; 43(4):1884-90. PubMed ID: 6831424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low urinary estrogen glucuronides in women at risk for familial breast cancer.
    Fishman J; Fukushima DK; O'Connor J; Lynch HT
    Science; 1979 Jun; 204(4397):1089-91. PubMed ID: 451553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary excretion of estrogen and pregnanediol in HCG-pseudopregnancy and during normal early pregnancy].
    Kaiser R; Geiger W
    Acta Endocrinol (Copenh); 1971 Jun; 67(2):331-6. PubMed ID: 5108491
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer.
    Henderson BR; Gerkins V; Rosario I; Casagrande J; Pike MC
    N Engl J Med; 1975 Oct; 293(16):790-5. PubMed ID: 1160970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.